A SYSTEMATIC REVIEW OF RISK FACTORS OF ADVERSE DRUG REACTIONS IN HOSPITALIZED PATIENTS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i10.27759Keywords:
Adverse drug reactions, Risk factors, Elderly patients, Adult patients, Logistic regressionAbstract
Background: Adverse drug reactions (ADRs) pose both financial and health encumbrances for patients. Although prevalence and risk factors associated with ADRs have been published in many studies, most of them lack the statistical evidence for predictors. The aim of this study was to review the published literature to determine the risk factors in the adult and elderly population for ADRs. An electronic search of articles published in English language in databases such as Cochrane Database of Systematic Reviews, MEDLINE, EMBASE, Scopus, and Google Scholar was conducted in between January 2001 and April 2018. The search terms used were: ADRs,†drug-related problems,†risk factors,†general adult population,†elderly patients,†and hospital admission.†For inclusion in the review, studies had to include an explicit definition of what was considered an ADR and/or an explicit assessment of causality, as well as a clear description of the method used for ADR identification. Polypharmacy was the major risk factor of ADR followed by comorbidities and length of hospital stay.
Downloads
References
Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM, HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890-6.
Hughes RG, Blegen MA. Patient Safety and Quality: An Evidence- Based Handbook for Nurses: Medication Administration Safety. Rockville: Agency for Healthcare Research and Quality (US); 2008.
Ozcan G, Aykac E, Kasap Y, Nemutlu NT, Sen E, Aydinkarahaliloglu ND. Adverse drug reaction reporting pattern in Turkey: Analysis of the national database in the context of the first pharmacovigilance legislation. Drugs Real World Outcomes 2016;3:33-43.
Al-Naher A, Wright D, Devonald MA, Pirmohamed M. Renal function monitoring in heart failure-what is the optimal frequency? A narrative review. Br J Clin Pharmacol 2018;84:5-17.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004;329:15-9.
Wester K, Jönsson AK, Spigset O, Druid H, Hägg S. Incidence of fatal adverse drug reactions: A population based study. Br J Clin Pharmacol 2008;65:573-9.
Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998;45:301-8.
Cahir CC, Curran C, Byrne C, Walsh C, Hickey A, Williams DJ, et al. Adverse drug reactions in an ageing population (ADAPT) study protocol: A cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients. BMJ Open 2017;7:1-12.
Investigational New Drug Application. Department of Health and Human Services. FDA. Code of Federal Regulations 2017;5. title 21. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/ cfCFR/CFRSearch.cfm?fr=312.3. [Last accessed on 2018 May 23].
International Drug Monitoring: The Role of National Centres. Report of a WHO meeting. World Health Organ Tech Rep Ser 1972;498:1-25.
Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000;356:1255-9.
Mudigubba MK, Rajashekarachari Y, Dahiya S. Risk factors associated with adverse drug reactions in hospitalized patients. Int J Pharm Sci Res 2017;8:3847-54.
Ben-Yehuda A, Bitton Y, Sharon P, Rotfeld E, Armon T, Muszkat M, et al. Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: A cohort, case-control study. Drugs Aging 2011;28:491-500.
Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE prevention study group. Arch Intern Med 1999;159:2553-60.
Macedo AF, Alves C, Craveiro N, Marques FB. Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions. J Nurs Manag 2011;19:395-9.
Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalized children. International multicentre study. Eur J Clin Pharmacol 2012;68:801-10.
MartÃnez-Mir I, GarcÃa-López M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ, et al. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999;47:681-8.
Thürmann PA. Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 2001;24:961-8.
van den Bemt PM, Egberts AC, Lenderink AW, Verzijl JM, Simons KA, van der Pol WS, et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000;22:62-6.
Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoigne R. Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/ St. Gallen. Eur J Clin Pharmacol 2000;56:427-30.
Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, et al. Trends in hospital admissions for adverse drug reactions in England: Analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007;7:9.
Haile DB, Ayen WY, Tiwari P. Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India. Ethiop J Health Sci 2013;23:39-48.
Angamo MT, Curtain CM, Chalmers L, Yilma D, Bereznicki L. Predictors of adverse drug reaction-related hospitalisation in southwest Ethiopia: A prospective cross-sectional study. PLoS One 2017;12:e0186631.
Javadi MR, Shalviri G, Gholami K, Salamzadeh J, Maghooli G, Mirsaeedi SM, et al. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: Incidence, severity and risk factors. Pharmacoepidemiol Drug Saf 2007;16:1104-10.
Wawruch M, Zikavska M, Wsolova L, Kuzelova M, Kahayova K, Strateny K, et al. Adverse drug reactions related to hospital admission in Slovak elderly patients. Arch Gerontol Geriatr 2009;48:186-90.
Harugeri A, Parthasarathi G, Ramesh M, Guido S, Basavanagowdappa H. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals. J Postgrad Med 2011;57:189-95.
Connor MO, Gallagher P, Byrne S, Mahony DO. Adverse drug reactions in older patients during hospitalisation: Are they predictable? Age Ageing 2012;41:771-6.
Chen YC, Fan JS, Chen MH, Hsu TF, Huang HH, Cheng KW, et al. Risk factors associated with adverse drug events among older adults in emergency department. Eur J Intern Med 2014;25:49-55.
Tangiisuran B, Scutt G, Stevenson J, Wright J, Onder G, Petrovic M, et al. Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton adverse drug reactions risk (BADRI) model. PLoS One 2014;9:e111254.
Nair NP, Chalmers L, Connolly M, Bereznicki BJ, Peterson GM, Curtain C, et al. Prediction of hospitalization due to adverse drug reactions in elderly community dwelling patients (The PADR-EC Score). PLOS One 2016;11:e0165757.
Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: A systematic literature review. Br J Clin Pharmacol 2015;80:808-17.
Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 2017;73:759-70.
Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 2014;9:2079-86.
Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006;54:226-33.
Mudigubba MK, Rajashekarachari Y, Dahiya S. Evaluation of predisposing factors associated with suspected adverse drug reactions of hospitalized patients. J Young Pharm 2018;10:202-7.
Admassie E, Melese T, Mequanent W, Hailu W, Srikanth BA. Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar teaching referral hospital, north west Ethiopia. J Adv Pharm Technol Res 2013;4:183-9.
Wochenschr K. Poly-pharmacy, inappropriate prescribing and adverse drug reactions in Austria. Mid Euro J Med 2008;20:713-4.
Cadieux RJ. Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgrad Med 1989;86:179-86.
Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA 1997;277:307-11.
Nolan L, O’Malley K. Prescribing for the elderly. Part 1: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988;36:142-9.
Siddiqui S, Baig MM, Jaffer S, Ansar SF. Study on prevalence of adverse drug reactions in patients suffering from tuberculosis in a tertiary care hospital. Int J Pharm Pharm Sci 2016;8:375-7.
Kumar L. Pharmacovigilance/reporting adverse drug reactions: An approach to enhance health surveillance and extending market share by minimizing the chances of drug withdrawals. Int J Pharm Pharm Sci 2015;7:1-7.
Andrews LB, Stocking C, Krizek T, Gottlieb L, Krizek C, Vargish T, et al. An alternative strategy for studying adverse events in medical care. Lancet 1997;349:309-13.
Weingart SN, Wilson RM, Gibberd RW, Harrison B. Epidemiology of medical error. BMJ 2000;320:774-7.
Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: A systematic review of prospective observational studies. Ann Pharmacother 2008;42:1017-25.
Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S, et al. Drug-related problems in hospitals: A review of the recent literature. Drug Saf 2007;30:379-407.
RodrÃguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics 2003;21:623-50.
Tegeder I, Levy M, Muth-Selbach U, Oelkers R, Neumann F, Dormann H, et al. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol 1999;47:557-64.
Saha L, Pandhi P, Malhotra S, Sharma N. Adverse drug event (ADE) related Medical emergency department visits and hospital admissions: A prospective study from a North Indian referral hospital. J Clin Diag Res 2008;2:600-4.
Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998;316:1295-8.
Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147:755-65.
Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009;41:67-76.
Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions V. Clinical factors influencing susceptibility. Ann Intern Med 1966;65:629-40.
Mamatha K, Singh H, Thakur SR. A study of adverse drug reactions associated with antidepressant drugs among female patients attending department of psychiatry. Minerva Psychiatr 2017;58:90-6.
Mamatha K, Singh H, Thakur SR. A study of drug utilization pattern of psychotropic drugs among female patients with psychotic disorders: A prospective study. Minerva Psychiatr 2017;58:85-9.
Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions. BMC Med 2013;11:237.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
